Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tubeimoside injection for verruca plana
ChiCTR2000033533Phase 4Recruiting
- Sponsor
- Shaanxi Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tubeimoside in flat wart (2 arms), sponsored by Shaanxi Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Curative effect of disease. Started Jun 2020; status: recruiting.
02
Drugs
tubeimoside
03
Conditions
flat wart
Beyond the preview
Go deeper on ChiCTR2000033533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033533.